Dry eye disease affects millions of people and is often caused by the eyes’ inability to produce enough quality tears. For many, over-the-counter drops only provide short-lived relief. TRYPTYR (acoltremon ophthalmic solution) 0.003% represents a new approach. Instead of simply adding moisture, this prescription treatment helps stimulate the eye’s own natural tear production, targeting the underlying dysfunction that leads to discomfort.
Dry eye disease occurs when your eyes don’t produce enough tears or when the quality of tears isn’t sufficient to keep the eye surface properly lubricated. This imbalance can lead to symptoms such as burning, irritation, blurry vision, and a feeling of grit or dryness. Traditional therapies often focus on replacing tears, but stimulating natural tear production can provide a more effective and lasting solution.
TRYPTYR is a groundbreaking therapy that works at a cellular level to activate tear production. Its active ingredient, acoltremon ophthalmic solution 0.003%, interacts with specific receptors in the eye that are responsible for tear secretion. By activating these pathways, the medication encourages the eyes to restore their own tear film balance, providing more natural and consistent moisture.
Unlike artificial tears, which require frequent application and don’t address the underlying dysfunction, TRYPTYR helps re-establish your eyes’ natural ability to stay hydrated and protected.
Healthy tear production relies on a complex interaction between the lacrimal glands, corneal nerves, and ocular surface tissues. When these systems aren’t working together properly, the eyes struggle to maintain moisture.
• Lacrimal gland activation: Tryptyr helps stimulate the glands that secrete the watery layer of your tears.
• Nerve signaling: By enhancing communication between the ocular surface and nerves, Tryptyr promotes a feedback loop that improves tear secretion.
• Long-term support: Rather than just coating the eye, Tryptyr addresses the dysfunction behind tear instability, supporting long-term relief.
• Targets the root cause of dry eye disease.
• Promotes natural tear production instead of relying solely on artificial solutions.
• Clinically proven to reduce the signs and symptoms of dry eye.
For patients frustrated with constant use of lubricating drops and persistent discomfort, Tryptyr offers a science-backed approach that fits into a long-term treatment plan.
Dry eye disease can significantly impact your comfort and quality of life. With the development of TRYPTYR (acoltremon ophthalmic solution) 0.003%, patients now have access to a treatment that goes beyond symptom management - helping restore the body’s own natural ability to keep eyes healthy and comfortable.
If you are struggling with dry, irritated eyes, it may be time to explore advanced treatments like Tryptyr. Schedule a consultation with Roosevelt Vision to discuss whether this innovative prescription therapy is right for you. Visit our office in Seattle, Washington, or call (206) 527-2987 to book an appointment today.